Skip to main content

Table 2 Procedural features in patients with FMD <4.2 % and ≥4.2 %

From: Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents

 

FMD <4.2 % (n = 40 )

FMD ≥ 4.2 % (n = 40 )

p

Target vessel artery

1.08 ± 0.27 (43 lesions)

1.23 ± 0.53 (49 lesions)

0.12

Left mail trunk, n (%)

3 (7.0)

5 (10.2)

0.46

Left anterior descending, n (%)

12 (27.9)

25 (51.0)

<0.01

Left circumflex, n (%)

16 (37.2)

12 (24.5)

0.35

Right coronary disease, n (%)

12 (27.9)

7 (14.3)

0.19

Multivessel coronary disease, n (%)

19 (47.5)

20 (50.0)

0.82

Lesion type B/C2, n (%)

40 (100)

39 (97.5)

0.31

Number of stets per lesion, n (%)

1.3 ± 0.6

1.3 ± 0.7

0.73

Stent diameter (mm)

3.03 ± 0.55

2.85 ± 0.51

0.13

Total stent length (mm)

22.4 ± 14.2

28.3 ± 16.9

0.09

Use of drug eluting stent (%)

27 (67.5)

31 (77.5)

0.32

Stent deployment pressure (atm)

18.3 ± 4.3

18.3 ± 4.5

0.98